Qlaris Bio appoints Fred Guerard as President and CEO
Qlaris Bio has appointed Fred Guerard as president and CEO. Guerard will also join the Board of Directors.
Read More
Author: Lucy Batizovsky
- 1
- 2
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
